Statement 17 Oct 2023

Innovative pharmaceutical industry statement on draft WHO Pandemic Treaty: We need to preserve what went well and address what went wrong

On 16 October 2023, IFPMA issued a statement in response to draft WHO Pandemic Treaty.

Read more
External study 16 Oct 2023

The value of vaccines to mitigate antimicrobial resistance

A report published by One Health Trust makes an urgent call for increasing vaccination coverage to tackle the growing threat of antimicrobial resistance (AMR) in low- and middle-income countries.

Read more
Expert insight 13 Oct 2023

Innovation and equity: at the core of future pandemic responses

In this year’s edition of Health: A Political Choice – From Fragmentation to Integration, Thomas Cueni focuses on the lessons learned from COVID-19. When the next pandemic hits, the success of our response will depend on how well we react to the lessons learned from Covid-19.  The world was ill prepared for the pandemic, costing millions of...

Read more
Expert insight 13 Oct 2023

How will vaccines save us from future threats?

The groundbreaking work of Professors Katalin Karikó and Drew Weissman was recently recognized, as they were awarded this year’s Nobel Prize in Physiology and Medicine. Their award was recognition for the research that ultimately enabled the development of safe and effective mRNA vaccines against COVID-19, and which has now spurred further research into how the...

Read more
Statement 12 Oct 2023

IFPMA statement on NCDs progress at the 70th WHO EMRO Regional Committee

On 12 October in Cairo, Egypt, IFPMA submitted a statement at the 70th WHO EMRO Regional Committee on agenda item EM/RC70/INF.DOC.8: Progress report on accelerating regional implementation of the Political Declaration of the Third High-Level Meeting of the General Assembly on the Prevention and Control of NCDs. 

Read more
Statement 11 Oct 2023

IFPMA statement on NCDs in emergencies at the 70th WHO EMRO Regional Committee

On 11 October 2023 in Cairo, Egypt at the WHO EMRO Regional Committee, IFPMA submitted a statement on addressing non-communicable diseases: a regional framework for action.

Read more
Press release 5 Oct 2023

Four innovators awarded Africa Young Innovators for Health Award for contributions to Universal Health Coverage

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and Speak Up Africa have announced the winners of the second edition of the Africa Young Innovators for Health Award.

Read more
Statement 2 Oct 2023

Fifth meeting of the Working Group on Amendments to the International Health Regulations (2005)

On 2 October, IFPMA delivered a statement at the fifth meeting of the Working Group on Amendments to the International Health Regulations (WGIHR) (2005) in Geneva.

Read more
Expert insight 28 Sep 2023

Vaccines can unlock a brighter future for people around the world

With a vaccine pipeline that can tackle today’s and tomorrow’s challenges, the life-saving potential of vaccines is more far-reaching than we know. From routine childhood immunisation to seasonal flu or COVID-19, vaccines are important for our health. In fact, four million deaths are prevented each year from childhood vaccination alone. Within the next seven years,...

Read more
Statement 26 Sep 2023

IFPMA and industry leaders applaud 10 years of collective action on ethics and business integrity in APEC region

Washington, D.C. and Geneva, 26 September 2023: This week, IFPMA joins hundreds of stakeholders from across economies in the Asia-Pacific at the APEC Business Ethics for SMEs Forum to recognize and applaud progress made by the initiative in the past decade to advance business ethics in the medical device and biopharmaceutical sectors in the region....

Read more
Statement 25 Sep 2023

IFPMA statement at PAHO 60th Directing Council – Agenda item 4.4

On 25 September 2023 in Washington, DC, USA, IFPMA submitted a statement at the 60th Directing Council of the Pan American Health Organization (PAHO) on agenda item 4.4: Policy on Prevention and Control of Noncommunicable Diseases in Children, Adolescents, and Young Adults.

Read more
Statement 22 Sep 2023

Statement at the High Level Meeting on Tuberculosis

On 22 September 2023, IFPMA submitted a statement at the High-Level Meeting on Tuberculosis in New York.

Read more